Last deal

$27M

Amount

Venture - Series Unknown

Stage

29.09.2020

Date

2

all rounds

$29M

Total amount

General

About Company
Viridian Therapeutics develops new treatments for underserved diseases in biotechnology.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Viridian Therapeutics, Inc.

founded date

01.01.2019

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Viridian Therapeutics is a privately held biotechnology company focused on advancing new treatments for patients with diseases that are underserved by today’s therapies.
Contacts